InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,925.20
(
-0.34%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.54
(
-2.74%
)
Bitcoin
58,413.66
(
-3.61%
)
Post# of 251670
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Rocky3 post# 213329

Friday, 09/01/2017 9:56:30 AM

Friday, September 01, 2017 9:56:30 AM

Post# of 251670
ENTA—Mavyret scripts* more than doubled to 127 for the week ending 8/25, up from 60 in the prior week.

The absolute numbers are low because IMS (presumably) is not fully capturing the government portion of the HCV market, where ABBV is focusing its Mavyret marketing.

*As reported by IMS.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up